Serum lipoprotein(a) is not modified by interleukin-6 receptor antagonism or associated with inflammation in non-ST-elevation myocardial infarction

MLA

Jan Kristian Damås, et al. “Serum Lipoprotein(a) Is Not Modified by Interleukin-6 Receptor Antagonism or Associated with Inflammation in Non-ST-Elevation Myocardial Infarction.” International Journal of Cardiology, vol. 274, Jan. 2019, pp. 348–50. EBSCOhost, https://doi.org/10.1016/j.ijcard.2018.06.093.

APA

Jan Kristian Damås, Rune Wiseth, Pål Aukrust, Arne Yndestad, Kirsten B. Holven, Thor Ueland, Annika E. Michelsen, Ola Kleveland, Lars Gullestad, & Bente Halvorsen. (2019). Serum lipoprotein(a) is not modified by interleukin-6 receptor antagonism or associated with inflammation in non-ST-elevation myocardial infarction. International Journal of Cardiology, 274, 348–350. https://doi.org/10.1016/j.ijcard.2018.06.093

Chicago

Jan Kristian Damås, Rune Wiseth, Pål Aukrust, Arne Yndestad, Kirsten B. Holven, Thor Ueland, Annika E. Michelsen, Ola Kleveland, Lars Gullestad, and Bente Halvorsen. 2019. “Serum Lipoprotein(a) Is Not Modified by Interleukin-6 Receptor Antagonism or Associated with Inflammation in Non-ST-Elevation Myocardial Infarction.” International Journal of Cardiology 274 (January): 348–50. doi:10.1016/j.ijcard.2018.06.093.